Infertility Drugs Market

Infertility Drugs Market Trends | Size, Share and Growth 2022-27

Market Overview 2022-2027:

The latest research study “Infertility Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global infertility drugs market reached a value of US$ 3.47 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.95 Billion by 2027 exhibiting a CAGR of 5.70% during 2022-2027.

Request a PDF Sample Copy for more detailed market insights:

Industry Definition and Application:

Infertility drugs are medicines used to cure infertility and improve the reproductive health of an individual. They are either consumed orally or injected to enhance the quality of sperm and restore the testosterone level in males. In contrast, they stimulate ovulation and follicle development of the ovary in females.

What are the major market drivers in the infertility drugs market?

One of the primary factors driving the market is the rising prevalence of infertility, miscarriage, polycystic ovary syndrome (PCOS) cases, breast and urinary cancers, diabetes, obesity and thyroid. Additionally, the sedentary lifestyles and delayed pregnancies are declining the fertility rates, thus propelling the market growth. Besides this, the consumption of alcohol, drugs and smoking is accelerating the adoption rates.

Furthermore, extensive investment in the research and development (R&D) activities and various initiatives taken by governments of different nations to spread awareness about the availability of these treatments are escalating the product demand. Moreover, rising public funding for developing these drugs and rapid approvals from regulatory bodies are creating a positive market outlook. Several other growth-inducing factors include the expanding healthcare industry, rising disposable income levels, technological upgradations, rapid urbanization, and increasing demand for generic medicines.

Click here to view detailed information with table of content:

Infertility Drugs Market Report Scope
Report CoverageDetails
Market size value in 2021US$ 3.47 Billion
Market forecast in 2027US$ 4.95 Billion
Growth RateCAGR of 5.70% from 2022 to 2027
Base year for estimation2021
Historical data2016-2021
Forecast period2022-2027
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredDrug Class, Route of Administration, Distribution Channel, End User and Region
Regional scopeNorth America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Key companies profiledAbbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.
Market DynamicsParent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,
Customization previewIf our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Report Segmentation:

The report has segmented the market on the basis of region, drug class, route of administration, distribution channel and end user.

Breakup by Drug Class:

  • Gonadotropin
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Biguanides
  • Others

Breakup by Route of Administration:

  • Oral
  • Intravenous
  • Subcutaneous
  • Intramuscular

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Breakup by End User:

  • Male
  • Female

Breakup By Geography:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

List of Major Key Players:

The major players in the market are Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *